These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38553897)

  • 1. Early-onset indicators of a hypercoagulable state and clinical complications in a cohort of children with sickle cell trait.
    Reggiani G; Boaro MP; Menzato F; De Bon E; Bertomoro A; Casonato A; Lucente F; Fortino C; Sartori M; Steffan A; Martella M; D'Agnolo M; Sainati L; Colombatti R
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30971. PubMed ID: 38553897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
    Gupta S; Carmona R; Malvar J; Young G
    Thromb Res; 2017 Mar; 151():44-50. PubMed ID: 28110132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.
    Al-Awadhi A; Adekile A; Marouf R
    J Thromb Thrombolysis; 2017 Jan; 43(1):117-123. PubMed ID: 27613177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity.
    Al-Awadhi A; Adekile A; Marouf R
    Acta Haematol; 2021; 144(2):182-189. PubMed ID: 32987383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS-13-VWF axis in sickle cell disease patients.
    Ladeira VS; Barbosa AR; Oliveira MM; Ferreira LGR; de Oliveira Júnior WV; de Oliveira Renó C; Reis EA; Chaves DG; Dusse LMS; Dos Santos HL; de Barros Pinheiro M; Rios DRA
    Ann Hematol; 2021 Feb; 100(2):375-382. PubMed ID: 33404693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
    Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
    J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy.
    Colombatti R; De Bon E; Bertomoro A; Casonato A; Pontara E; Omenetto E; Saggiorato G; Steffan A; Damian T; Cella G; Teso S; Manara R; Rampazzo P; Meneghetti G; Basso G; Sartori MT; Sainati L
    PLoS One; 2013; 8(10):e78801. PubMed ID: 24205317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation activation in sickle cell trait: an exploratory study.
    Amin C; Adam S; Mooberry MJ; Kutlar A; Kutlar F; Esserman D; Brittain JE; Ataga KI; Chang JY; Wolberg AS; Key NS
    Br J Haematol; 2015 Nov; 171(4):638-46. PubMed ID: 26511074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered von Willebrand Factor and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension.
    Islek A; Ilhan D; Ozturk N; Guven B; Sag E
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e951-e956. PubMed ID: 33369998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease.
    van der Land V; Peters M; Biemond BJ; Heijboer H; Harteveld CL; Fijnvandraat K
    Thromb Res; 2013; 132(6):712-7. PubMed ID: 24182550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the level of von willebrand factor and ADAMTS13 in sickle cell anaemia patients in steady state.
    Kingsley A; Ofonime E; Enobong U; Iquo I
    Niger J Clin Pract; 2022 Sep; 25(9):1393-1397. PubMed ID: 36149195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
    Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
    J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride/HDL-cholesterol ratio and plasminogen activator inhibitor-1 independently predict high pulse pressure in sickle cell trait and disease.
    Olabode OP; Akinlade OM; Babatunde AS; Abdulazeez MI; Biliaminu SA; Oyabambi AO; Olatunji VA; Soladoye AO; Olatunji LA
    Arch Physiol Biochem; 2020 May; 126(2):166-171. PubMed ID: 30145922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAMTS13 activity in sickle cell disease.
    Schnog JJ; Kremer Hovinga JA; Krieg S; Akin S; Lämmle B; Brandjes DP; Mac Gillavry MR; Muskiet FD; Duits AJ;
    Am J Hematol; 2006 Jul; 81(7):492-8. PubMed ID: 16755558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation.
    Mohan JS; Lip GY; Wright J; Bareford D; Blann AD
    Blood Coagul Fibrinolysis; 2005 Apr; 16(3):209-14. PubMed ID: 15795541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procoagulant activity in patients with sickle cell trait.
    Lawrie AS; Pizzey A; Trompeter S; Meiselman H; Mohandas N; Dumanski JP; Westerman MP
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):268-70. PubMed ID: 22343687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13.
    Djamiatun K; van der Ven AJ; de Groot PG; Faradz SM; Hapsari D; Dolmans WM; Sebastian S; Fijnheer R; de Mast Q
    PLoS Negl Trop Dis; 2012; 6(5):e1628. PubMed ID: 22563509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease.
    Zhou Z; Han H; Cruz MA; López JA; Dong JF; Guchhait P
    Thromb Haemost; 2009 Jun; 101(6):1070-7. PubMed ID: 19492149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.
    Hoogenboom WS; Alamuri TT; McMahon DM; Balanchivadze N; Dabak V; Mitchell WB; Morrone KB; Manwani D; Duong TQ
    Blood Rev; 2022 May; 53():100911. PubMed ID: 34838342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of ADAMTS13-independent VWF regulation in sickle cell disease.
    Hunt RC; Katneni U; Yalamanoglu A; Indig FE; Ibla JC; Kimchi-Sarfaty C
    J Thromb Haemost; 2022 Sep; 20(9):2098-2108. PubMed ID: 35753044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.